Prudential Financial Inc Oric Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.54 - $16.1 $159,944 - $567,203	-35,230 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.01 - $20.3 $2,462 - $4,161	-205 Reduced 0.58%	35,230 $564,000
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $6,042 - $9,583	380 Added 1.08%	35,435 $741,000
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $4,689 - $6,841	270 Added 0.78%	35,055 $620,000
Q1 2021 May 12, 2021	BUY	$23.67 - $36.85 $2,367 - $3,685	100 Added 0.29%	34,785 $852,000
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $704,799 - $1.38 Million	34,685 New	34,685 $1.17 Million

126

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $389M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.